American Century Companies’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-836,134
Closed -$24.8M 2987
2023
Q4
$24.8M Buy
836,134
+137,018
+20% +$2.73M 0.02% 792
2023
Q3
$11.1M Sell
699,116
-1,207
-0.2% -$20.1K 0.01% 1029
2023
Q2
$13.2M Buy
+700,323
New +$8.27M 0.01% 942
2022
Q1
Sell
-12,969
Closed -$96K 2372
2021
Q4
$96K Hold
12,969
﹤0.01% 2261
2021
Q3
$74K Sell
12,969
-2,013
-13% -$11.6K ﹤0.01% 2250
2021
Q2
$99K Sell
14,982
-5,962
-28% -$41.6K ﹤0.01% 2237
2021
Q1
$170K Buy
20,944
+10,301
+97% +$84.1K ﹤0.01% 2112
2020
Q4
$69K Buy
+10,643
New +$62.1K ﹤0.01% 1938
2016
Q1
Sell
-113,550
Closed -$1.54M 1383
2015
Q4
$1.54M Sell
113,550
-377
-0.3% -$4.64K ﹤0.01% 1061
2015
Q3
$1.09M Buy
113,927
+9,098
+9% +$133K ﹤0.01% 1103
2015
Q2
$1.51M Buy
+104,829
New +$1.15M ﹤0.01% 1077
2014
Q4
Sell
-80,058
Closed -$848K 1485
2014
Q3
$848K Buy
80,058
+4,074
+5% +$46.1K ﹤0.01% 1212
2014
Q2
$900K Buy
75,984
+23,304
+44% +$293K ﹤0.01% 1236
2014
Q1
$787K Sell
52,680
-4,200
-7% -$66.2K ﹤0.01% 1269
2013
Q4
$834K Buy
56,880
+170
+0.3% +$2.61K ﹤0.01% 1277
2013
Q3
$965K Buy
56,710
+3,550
+7% +$62.4K ﹤0.01% 1237
2013
Q2
$882K Buy
+53,160
New +$862K ﹤0.01% 1222

Other funds holding IMGN

American Century Companies's IMGN Position: Q1 2024 in Review

American Century Companies sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 836,134 shares — an estimated $24.8M sold.

American Century Companies first reported a position in IMGN in Q2 2013 and held it in 17 quarters. The position peaked at $24.8M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • American Century Companies reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • American Century Companies sold 836,134 Immunogen Inc shares in Q1 2024, an estimated $24.8M.
  • American Century Companies first reported a position in Immunogen Inc in Q2 2013 and held it in 17 quarters.
  • American Century Companies's Immunogen Inc position peaked at $24.8M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on American Century Companies's 13F filing for Q1 2024, filed 14 May 2024.